These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19954405)

  • 1. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination.
    de Aguiar MM; de Albuquerque RP; Marinho DS; Braga BR; Dornelas CB; Oliveira A; de Sousa VP; Torres SR; Alviano DS; Alviano CS; Cabral LM; Holandino C
    Drug Dev Ind Pharm; 2010 May; 36(5):594-600. PubMed ID: 19954405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance.
    Llabot JM; Manzo RH; Allemandi DA
    J Pharm Sci; 2009 May; 98(5):1871-6. PubMed ID: 18803261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of purified cashew gum mucoadhesive buccal tablets containing nystatin for treatment of oral candidiasis.
    Magalhães APSPA; Toma HK; do Carmo FA; Mansur CRE
    Drug Dev Ind Pharm; 2021 May; 47(5):825-837. PubMed ID: 34033502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets.
    Sakeer K; Al-Zein H; Hassan I; Martin GP; Nokhodchi A
    Pharm Dev Technol; 2010; 15(4):360-8. PubMed ID: 19772376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-layered mucoadhesive tablets containing nystatin.
    Llabot JM; Manzo RH; Allemandi DA
    AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary nystatin concentrations after administration of an osmotic controlled release tablet and a pastille.
    Encarnacion M; Chin I
    Eur J Clin Pharmacol; 1994; 46(6):533-5. PubMed ID: 7995321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nystatin pastilles and suspension in the treatment of oral candidosis.
    Millns B; Martin MV
    Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation.
    Sakeer K; Al-Zein H; Hassan I; Desai S; Nokhodchi A
    Arch Pharm Res; 2010 Nov; 33(11):1771-9. PubMed ID: 21116780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucoadhesive oral tablets--a modern dosage form with controlled drug release].
    Dostálová M; Rabisková M
    Ceska Slov Farm; 2000 Mar; 49(2):55-61. PubMed ID: 10953444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies.
    Fernández Campos F; Calpena Campmany AC; Rodríguez Delgado G; López Serrano O; Clares Naveros B
    J Pharm Sci; 2012 Oct; 101(10):3739-52. PubMed ID: 22777575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal excretion of nystatin during and after oral administration to newborn infants at risk].
    Blaschke-Hellmessen R; Pannwitz U; Schwarze R
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):89-91. PubMed ID: 2038352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nystatin and lidocaine pastilles for the local treatment of oral mucositis.
    Silva FC; Marto JM; Salgado A; Machado P; Silva AN; Almeida AJ
    Pharm Dev Technol; 2017 Mar; 22(2):266-274. PubMed ID: 27499389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of dipyridamole in pharmaceutical preparations using square wave voltammetry.
    de Toledo RA; Castilho M; Mazo LH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1113-7. PubMed ID: 15620540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation.
    Thompson PJ; Wingfield HJ; Cosgrove RF; Hughes BO; Turner-Warwick ME
    Br Med J (Clin Res Ed); 1986 Jun; 292(6537):1699-700. PubMed ID: 3089361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research studies on the quality of bio-mucoadhesive tablets containing miconazole nitrate.
    Birsan M; Popovici I; Palade L; Cojocaru I
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):257-62. PubMed ID: 24505925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sugar-free nystatin mixture should be used in the treatment of oral candidiasis].
    Wahlin YB; Wahlin A; Leksell E
    Lakartidningen; 1992 Apr; 89(18):1556. PubMed ID: 1579017
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
    Goins RA; Ascher D; Waecker N; Arnold J; Moorefield E
    Pediatr Infect Dis J; 2002 Dec; 21(12):1165-7. PubMed ID: 12506950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed hypersensitivity to oral nystatin.
    Martínez FV; Muñoz Pamplona MP; García EC; Urzaiz AG
    Contact Dermatitis; 2007 Sep; 57(3):200-1. PubMed ID: 17680880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.